Hepatitis C: Grading and Staging by MR
NCT00059397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2010-03-18
Summary
To compare MR imaging findings with biopsy for grading and staging early hepatitis C.
Conditions
- Hepatitis
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
lead NIH
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-04-30
Countries
- United States
Study Locations
More Related Trials
-
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
NCT00735969 ·Status: COMPLETED ·Phase: PHASE2
-
New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
NCT01888900 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
NCT00703560 ·Status: COMPLETED
-
Immune Response to Hepatitis C Virus
NCT00165919 ·Status: WITHDRAWN
-
Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada
NCT01100749 ·Status: TERMINATED
-
HEPATITIS C SCREENING in ADULTS with RISK FACTORS in FIVE CITIES of COLOMBIA'S CARIBBEAN COAST (FIVE-CC)
NCT06899542 ·Status: NOT_YET_RECRUITING
-
Hepatitis C Virus and the Humoral Immune System
NCT00219999 ·Status: COMPLETED
-
Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients
NCT00146016 ·Status: COMPLETED ·Phase: PHASE3
-
Hepatitis C Antiviral Resistance in African-Americans
NCT00038974 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection
NCT00164073 ·Status: UNKNOWN
-
Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C
NCT06564051 ·Status: TERMINATED
-
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
NCT00056862 ·Status: COMPLETED ·Phase: PHASE4
-
MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)
NCT00857311 ·Status: COMPLETED ·Phase: PHASE1
-
High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV
NCT00381953 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
NCT00759200 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Inpatient Screening for Hepatitis C
NCT04525690 ·Status: COMPLETED ·Phase: NA
-
Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)
NCT05906459 ·Status: UNKNOWN
-
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood
NCT02718573 ·Status: COMPLETED
-
Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease
NCT00028093 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)
NCT00828269 ·Status: COMPLETED ·Phase: PHASE1
-
Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
NCT06508996 ·Status: COMPLETED
-
Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)
NCT01508156 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C
NCT00322179 ·Status: COMPLETED
-
Long-term Follow-up of HALT-C Sustained Virological Responders
NCT00825877 ·Status: COMPLETED
-
Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002)
NCT02392494 ·Status: COMPLETED ·Phase: PHASE1